Funding for this research was provided by:
Grünenthal España (.)
Article History
Received: 10 June 2019
Revised: 10 June 2019
Accepted: 4 August 2019
First Online: 16 August 2019
Compliance with ethical standards
:
: María Presa and Itziar Oyagüez are employees of Pharmacoeconomics & Outcomes Research Iberia (PORIB), a consultant company specializing in healthcare outcomes research and economic evaluation of health technology, which received unrestricted financial support by Grünenthal to assist with the local adaptation of the model and manuscript drafting. Fernando Pérez-Ruiz has received fees from Grünenthal for advisory work.